相关实验视频
Updated: Jul 21, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
345
低性低性性甲状腺毒性周期性与双极性障碍相关的治疗疗法
Talia E Rave1, Marina Movshovich2
1Department of Internal Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA.
Cureus
|July 28, 2023
概括
甲状腺毒性周期性 (TPP) 是甲状腺功能障碍症的一种罕见并发症. 这一案例凸显了双相情感障碍的甲状腺激素治疗导致的风险,强调了仔细监测.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 甲状腺毒性周期性 (TPP) 是甲状腺功能障碍症的一种罕见并发症,其特征是由于转移到细胞中而导致低血.
- 甲状腺激素水平的升高与TPP的发病有关.
- 甲状腺激素在治疗双相情感障碍中的作用正在调查中,一些研究正在探索其潜在的益处.
研究的目的:
- 在接受liothyronine的双相情绪障碍患者中报告TPP病例.
- 突出甲状腺激素补充在精神病管理中的潜在风险.
- 强调密切监测甲状腺功能的重要性.
主要方法:
- 一个37岁的男性患有甲状腺功能低下症和双相情感障碍的病例报告.
- 甲氨酸被用于双相情感障碍的管理.
- 分析了临床表现,实验室发现 (低血,低血,无法检测到的TSH) 和治疗.
主要成果:
- 该患者出现了双边下肢和严重的低血清症.
- 对TPP的诊断得到了证实.
- 在24小时内,通过保守的补充来纠正电解质.
结论:
- 补充甲状腺激素的使用可以导致严重的并发症,如TPP.
- 阳性甲状腺功能过高和TPP需要警的甲状腺功能监测.
- 需要进一步的研究来确定甲状腺激素在情绪障碍中的作用.
相关概念视频
Mania and Antimanic Drugs: Overview
246
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
246
Bipolar Disorder
106
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
106
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Antiepileptic Drugs: Potassium Channel Activators
214
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
214
Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
Antihypertensive Drugs: Potassium-Sparing Diuretics
642
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
642

